Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole for Chronic Bronchopulmonary Aspergillosis
NCT00159822Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2005
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole in chronic pulmonary aspergillosis (CPA), sponsored by Pfizer. Started Jul 2005; status: completed.
02
Drugs
voriconazole
03
Conditions
chronic pulmonary aspergillosis (CPA)
Beyond the preview
Go deeper on NCT00159822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159822.